Get the Stockscreener App
1.40
0.72%
0.01
Gri Bio Inc stock is traded at $1.40, with a volume of 83,975.
It is up +0.72% in the last 24 hours and down -31.37% over the past month.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
See More
Previous Close:
$1.39
Open:
$1.42
24h Volume:
83,975
Relative Volume:
0.36
Market Cap:
$3.52M
Revenue:
-
Net Income/Loss:
$-8.26M
P/E Ratio:
-0.0261
EPS:
-53.609
Net Cash Flow:
$-12.17M
1W Performance:
+0.72%
1M Performance:
-31.37%
6M Performance:
-80.16%
1Y Performance:
-83.54%
1-Day Range:
$1.35
$1.43
1-Week Range:
$1.35
$1.57
52-Week Range:
$1.10
$30.43
Gri Bio Inc Stock (GRI) Company Profile
Name
Gri Bio Inc
Sector
Industry
Phone
(619) 400-1171
Address
2223 AVENIDA DE LA PLAYA, LA JOLLA
Compare GRI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRI
Gri Bio Inc
|
1.40 | 3.67M | 0 | -8.26M | -12.17M | -53.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Gri Bio Inc Stock (GRI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-24 | Initiated | H.C. Wainwright | Buy |
Gri Bio Inc Stock (GRI) Latest News
Chart based exit strategy for GRI Bio Inc.2025 Buyback Activity & Safe Capital Growth Stock Tips - Newser
Trapped Investors in GRI Bio Inc. Await Breakout SignalJuly 2025 Price Swings & Low Risk Growth Stock Ideas - newsyoung.net
Analyzing drawdowns of GRI Bio Inc. with statistical toolsWeekly Volume Report & Community Shared Stock Ideas - Newser
Advanced analytics toolkit walkthrough for GRI Bio Inc.July 2025 PreEarnings & Consistent Profit Trading Strategies - Newser
Quantitative breakdown of GRI Bio Inc. recent moveQuarterly Earnings Summary & Target Return Focused Stock Picks - Newser
Is GRI Bio Inc. stock entering bullish territoryTake Profit & Verified Swing Trading Watchlist - Newser
Can a trend reversal in GRI Bio Inc. lead to recoveryForecast Cut & Smart Money Movement Alerts - Newser
GRI Bio Inc. stock prediction for this weekJuly 2025 Volume & Risk Managed Investment Signals - Newser
Will GRI Bio Inc. rebound enough to break evenTrade Exit Summary & Verified Entry Point Signals - Newser
How to use a screener to detect GRI Bio Inc. breakoutsTrade Analysis Report & Low Drawdown Investment Strategies - Newser
Developing predictive dashboards with GRI Bio Inc. dataJuly 2025 Catalysts & Smart Swing Trading Alerts - Newser
Custom strategy builders for tracking GRI Bio Inc.Weekly Profit Recap & Verified Technical Trade Signals - Newser
Using data models to predict GRI Bio Inc. stock movementJuly 2025 Movers & Reliable Entry Point Alerts - Newser
What the charts say about GRI Bio Inc. todayWeekly Stock Recap & High Yield Equity Trading Tips - Newser
What to expect from GRI Bio Inc. in the next 30 days2025 Earnings Impact & Technical Analysis for Trade Confirmation - Newser
Can GRI Bio Inc. Rally Enough to Break Even2025 Trading Volume Trends & Risk Controlled Stock Pick Alerts - beatles.ru
Is GRI Bio Inc. stock poised for growthQuarterly Profit Summary & Smart Allocation Stock Reports - Newser
Why GRI Bio Inc. stock attracts strong analyst attentionMarket Performance Summary & Weekly High Potential Alerts - Newser
GRI Bio Inc. Forms Bullish Flag — Upside Ahead2025 Top Decliners & Weekly Top Stock Performers List - thegnnews.com
Combining price and volume data for GRI Bio Inc.Market Sentiment Report & Free Low Drawdown Momentum Trade Ideas - Newser
GRI Bio Posts Q2 2025 Earnings Loss; Market Reacts with Mixed Signals - AInvest
Can GRI Bio Inc. withstand a market correctionJuly 2025 Patterns & Low Risk High Reward Trade Ideas - classian.co.kr
Combining machine learning predictions for GRI Bio Inc.Weekly Profit Report & Fast Exit and Entry Strategy Plans - Newser
Full technical analysis of GRI Bio Inc. stockWall Street Watch & Low Drawdown Investment Ideas - Newser
Regression analysis insights on GRI Bio Inc. performanceWeekly Trend Summary & Technical Entry and Exit Alerts - Newser
Technical signs of recovery in GRI Bio Inc.July 2025 Gainers & Consistent Growth Equity Picks - Newser
Does GRI Bio Inc. show high probability of rebound2025 Market Overview & Verified Swing Trading Watchlists - Newser
Gri Bio Inc Stock (GRI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):